Akynzeo Injection

Akynzeo Injection is an anti-emetic medication containing a fixed-dose combination of fosnetupitant and palonosetron. Fosnetupitant is a neurokinin-1 (NK-1) receptor antagonist, while palonosetron is a 5-HT3 receptor antagonist. This medication is used to prevent chemotherapy-induced nausea and vomiting (CINV) in cancer patients undergoing chemotherapy, and to control postoperative nausea and vomiting. It helps patients tolerate their chemotherapy treatments by reducing the likelihood of these distressing side effects.

Common side effects include hives, swollen face, breathing trouble, and chest pain. Inform your healthcare provider if these side effects persist or cause concern.

If you have liver problems or renal impairment, discuss this with your physician as dosing adjustments may be necessary.

There is a potential risk of serotonin syndrome when Akynzeo Injection is combined with other serotonergic medications. Serotonin syndrome can cause agitation, hallucinations, rapid heartbeat, fever, muscle stiffness, and coordination problems. Inform your physician about all medications you are taking, including antidepressants and other serotonergic drugs.

The safety and efficacy of Akynzeo Injection in paediatric patients have not been established. This medication is primarily intended for use in adults.

This drug is unsafe to administer to pregnant women because it may cause harm to the baby. It is unclear whether this drug passes into breast milk for breastfeeding women.

Chemotherapy-induced nausea and vomiting. Postoperative nausea and vomiting.

Akynzeo Injection is a fixed-dose combination of two active ingredients, fosnetupitant and palonosetron. Fosnetupitant is a neurokinin-1 (NK-1) receptor antagonist, while palonosetron is a 5-HT3 receptor antagonist. Together, they work by blocking specific receptors in the brain and gut that trigger nausea and vomiting, providing more effective control of these side effects.

The medicine can be given only as an intravenous injection into a vein by your physician in a hospital setting. Akynzeo Injection is usually administered as a 30-minute infusion before you receive your anti-cancer medicine (chemotherapy) or right before anesthesia for surgery.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Allergic reactions Hives Swollen face Breathing trouble Chest pain Common Headache Fatigue Dizziness Abdominal pain.

Proper hydration can help reduce the risk of CINV. Drink plenty of fluids, and inform your physician if you have difficulty keeping fluids down. Try to maintain a balanced diet when possible. Eating small, frequent meals and snacks throughout the day can help prevent nausea and vomiting. Stress and anxiety can worsen nausea. Engage in relaxation techniques, such as deep breathing exercises or meditation, to help manage stress. Adequate rest and sleep are also important during the treatment with Akynzeo Injection.